AI Business LensTHE BUSINESS OF AI, FOR PEOPLE WHO TEACH IT OR LEARN FROM IT
The Verge · November 11, 2026 · On the brief until November 25, 2026

Google’s AlphaGenome 2 zooms in on the cellular roots of disease

MedicineBiologyBiomedical Engineering
THE AI ANGLE
Predicting cell-specific effects of genetic mutations

Google DeepMind released AlphaGenome 2 to predict how genetic mutations alter gene expression across distinct cell types and states. The system helps biomedical researchers connect population genetics directly to cellular mechanisms and drug targets. Its detailed predictions require higher computational power than previous versions, restricting its use for entire genome scans.

Summary written by AI Business Lens with an AI model from the article at theverge.com. It is not the article, and the publisher has not reviewed it. For publishers.

THE TEACHING ANGLE
AlphaGenome 2 offers fine-grained predictions for specific cell states, but its heavy computational cost prevents researchers from using it across the entire human genome.

Read the original at theverge.com   Generate teaching or study materials

Instructors get discussion guides, assignments, and mini-cases. Students and readers get a plain summary, points to raise, an exercise, and a self-check. All built from the full article. A free account saves stories and gives you three generations. Stories stay on the brief for 14 days. After that this page keeps the link to the original.

More in Medicine